InVivo Therapeutics Holdings Corp
NVIV
NVIV was delisted on the 12th of February, 2024.
38 hedge funds and large institutions have $39.5M invested in InVivo Therapeutics Holdings Corp in 2015 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 10 increasing their positions, 3 reducing their positions, and 5 closing their positions.
233% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 3
65% more call options, than puts
Call options by funds: $3.91M | Put options by funds: $2.36M
20% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 5
3% more funds holding
Funds holding: 37 → 38 (+1)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
10% less capital invested
Capital invested by funds: $43.9M → $39.5M (-$4.44M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WF
Welch & Forbes
Boston,
Massachusetts
|
+$1.04M |
| 2 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$743K |
| 3 |
Goldman Sachs
New York
|
+$446K |
| 4 |
Group One Trading
Chicago,
Illinois
|
+$446K |
| 5 |
EIM
Emerson Investment Management
Boston,
Massachusetts
|
+$297K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$594K |
| 2 |
Citigroup
New York
|
-$297K |
| 3 |
TCIM
TIAA CREF Investment Management
New York
|
-$297K |
| 4 |
Millennium Management
New York
|
-$173K |
| 5 |
Bank of New York Mellon
New York
|
-$149K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Bessemer Group
Woodbridge,
New Jersey
| $2K | – | – | – |
|
|
FNBT
52
FineMark National Bank & Trust
Fort Myers,
Florida
| $2K | – | – | – |
|
53
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| $2K | – | – | – |
|
54
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| $131 | – | – | – |
|
|
CS
55
Credit Suisse
Zurich,
Switzerland
| – | -$94K | -1 | Closed |
|
|
56
Millennium Management
New York
| – | -$173K | -1 | Closed |
|
|
PG
57
PEAK6 Group
Chicago,
Illinois
| – | -$82K | -1 | Closed |
|
58
Barclays
London,
United Kingdom
| – | -$1K | – | – |
|
59
Citadel Advisors
Miami,
Florida
| – | -$13K | – | – |
|
|
SO
60
STRS Ohio
Columbus,
Ohio
| – | -$73K | – | – |
|
NVIV Hedge Fund Activity: Q4 2015 in Review
38 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in InVivo Therapeutics Holdings Corp (NVIV) for Q4 2015, worth a combined $39.5M — down 10% from $43.9M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new NVIV positions and 5 closed out — a net gain of 1 holder — while 10 added to existing stakes and 3 trimmed.
The largest buyer was Welch & Forbes, adding an estimated $1.04M. The largest seller was Susquehanna International Group, cutting an estimated $594K.
- 38 institutional investors held InVivo Therapeutics Holdings Corp (NVIV) as of Q4 2015, up from 37 in Q3 2015.
- Funds reported $39.5M of InVivo Therapeutics Holdings Corp stock for Q4 2015, down 10% quarter-over-quarter.
- 6 funds opened new InVivo Therapeutics Holdings Corp positions in Q4 2015 and 5 closed out, a net change of +1 holder.
- The largest InVivo Therapeutics Holdings Corp buyer in Q4 2015 was Welch & Forbes, an estimated $1.04M added.
- The largest InVivo Therapeutics Holdings Corp seller in Q4 2015 was Susquehanna International Group, an estimated $594K sold.
Based on aggregated 13F filings for Q4 2015.